Stock Track | Alvotech Plunges 5.04% After Hours on Q1 Earnings Miss and Revenue Decline

Stock Track
05/07

Alvotech's stock fell 5.04% in post-market trading on Wednesday, following the release of its first-quarter financial results.

The biotechnology company reported revenue of $105.9 million for Q1 2026, a 20.3% decrease from the same period last year and significantly below analyst estimates of $140.85 million. Earnings per share were breakeven, missing expectations of 2 cents per share.

CEO Lisa Graver stated that both revenues and EBITDA were impacted by a production slowdown related to facility improvements, with a recovery expected as normal operations resume. The company maintained its full-year revenue guidance of $650-$700 million and adjusted EBITDA guidance of $180-$220 million.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10